ClinicalTrials.Veeva

Menu

Outpatient Treatment of Severe and Enduring Anorexia Nervosa

H

Helsinki University Central Hospital (HUCH)

Status

Completed

Conditions

Anorexia

Treatments

Behavioral: Outpatient treatment of severe and enduring anorexia nervosa

Study type

Observational

Funder types

Other

Identifiers

NCT05708404
PISARAAVO

Details and patient eligibility

About

Approximately 20-30 % of individuals with the eating disorder anorexia nervosa develop an enduring form of the illness. In this study a new treatment for patients with severe and enduring anorexia nervosa was described. The treatment is flexible and aims at enhancing quality of life. The participants consisted of all referrals resulting in an assessment or treatment period at the unit between May 2017 and May 2022. The study was a registry study. Information regarding patient characteristics, treatment goals, and the course of treatment was gathered from medical records.

Enrollment

20 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

  • Age ≥ 18 years
  • A referral resulting in an assessment or treatment period at the unit for patients with severe and enduring anorexia nervosa at the HUS Helsinki University Hospital between May 2017 and May 2022.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems